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Abstract 
Background: Bacterial blood stream infections constitute a significant public-health problem and it is an 
important cause of morbidity and mortality in HIV infected patients. Little is known in developing countries 
regarding salmonella bacteraemia among HIV patients. The purpose of this study was to determine the bacterial 
pathogens causing blood stream infection among febrile adults attending three medical centers in Nasarawa 
State. Methods: A prospective cross-sectional study involving 346 consecutive, febrile adult patients admitted at 
three medical centers in Nasarawa State, was conducted. Demographic and other data were collected using 
standardized questionnaires. Blood culture was done followed by susceptibility testing using disc diffusion 
method. HIV testing was also performed as per Nigeria national algorithm and total white blood cell counts and 
CD4+ counts determined. Results: Of 346 febrile adult patients 33 (9.5%) had blood stream infections. The 
common isolates were Salmonella spp 13(39.4%), Escherichia coIi 8 (24.2%), Streptococcus pneumonia 
5(15.2%), Staphylococcus aureus 4(12.1%), Citrobacter spp 1(3%), Streptococcus pyogenes 1(3%) and 
Kiebsiella pneumonia 1(3%). A total of 156 (45.1%) patients were HIV infected; of whom 12/1 56 (7.6%) were 
infected by non-typhoid Salmonella spp compared to 1/190 (0.5%) of non-HIV infected patients (RRR 11.2, 
p=0.029) infected with Salmonella typhi. HIV infected patients with bacteremia had significantly lower CD4+ 
count than those without bacteremia (median 28 vs. 88 cells/mI, p=0.01). Patients with salmonella bacteremia 
had significantly lower median of WBC than those with non-salmonella as well as those without bacteremia 
(median, 3.6 vs. 17.5 vs. 9.8x109, p0.0001). All Salmonella spp were sensitive to ceftriaxone and imipenem, 
while being 84%, 69.2%, 38% and 8% resistant to chloramphenicol, ampicillin, sulphamethaxazole/trimethoprim 
and ciprofloxacin respectively. Predictors of mortality were HIV infection (OR 2.3, p=0.005), Glasgow coma 
score of less than 15 (OR 3.4, p=0.0001) and night sweats (OR 2.4, p=0.014). Conclusion: Non-typhoid 
Salmonella spp that are highly resistant to common antibiotics are predominant cause of bacterial blood stream 
infection among HIV patients attending Three tertiary medical centers in Nasarawa State. Continuous 
surveillance and intervention strategies should be put in place to monitor and manage cases of bloodstream 
infections in HIV-positive patients in  Nasarawa state.  
 
Background   
Globally burden of sepsis is substantial; in the United State of America (USA), severe sepsis claims 210,000 
lives per year [1]. The exact burden of bacteremia in the low and middle income countries remains unknown. 
The high incidence of bacterial, parasitic, and HIV infection suggests that bacteremia might be a substantial 
problem in developing countries [2]. A mortality rate of up to 38% among patients with bacteremia has been 
reported, with a strong correlation between HIV infection and bacteremia [3]. In Gambia, patients with positive 
blood cultures were more likely to die than those without bacteremia In many studies majority of bacteraemia are 
due to Staphylococcus aureus (including methicillin-resistant), Streptococcus pneumoniae, Pseudomonas spp, 
Salmone lla enterica, Escherjchja coli and disseminated tuberculosis. The pattern can differ between developed 
and low in-income countries [6-121. The use of blood culture to assess seriously ill patients infected with HIV 
has led to a growing understanding of their increased risk of a range of invasive bacterial and fungal disease 
including Streptococcus pneumoniae, disseminated tuberculosis, cryptococcosis, and Salmonella bacteremia 
[13,14]. Non —typhoid salmonella bacteremia has been identified as AIDS defining illness according to CDC 
and WHO [15]; while for Salmonella typhi infection HIV was found to be protective as demonstrated by Crump 
et al. [10]. The diagnosis of these infections can be confirmed by blood culture, which is routinely available in 
few hospitals in developing countries [2,16-18]. Factors thought to contribute to poor outcomes of critically ill 
patients in these settings include treatment cost, deficiency of diagnostic facilities and poor health seeking 
behavior [19,20]. Since bloodstream infections are common and associated with high mortality, improved 
clinical and microbiology services as well as reassessment of empirical treatment guidelines might contribute to 
better outcomes. In resource-constrained environment like ours, simple measures like timely provision of 
intravenous us fluid resuscitation coupled with prompt empirical antibiotics administration may improve 
outcomes. Identification of common organisms isolated in blood cultures and antimicrobial susceptibility testing 
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with regular data updates should promote appropriate antimicrobial prescribing and improve outcome of patients 
with bacteremia.  
Methods  
Study design  
A cross-sectional prospective study was conducted. This study was conducted in the medical wards at  Dalhatu 
Araft specialist Hospital Lafia,General Hospital Akwanga and Federal Medical Centre Keffi; all the medical 
center are tertiary referral center for the three senatorial Zone of the state, serving a total population of 2.6 
million in Nasarawa state.  
Sample size and sampling  
Sample size was determined using Kish and Leslie formula for cross-sectional studies [21]. Prevalence of 
bacteremia estimated from previous studies of 16.4% [5] was used. A minimum sample size obtained was 210 
but in the study 346 patients were enrolled. Patients with fever (defined as auxiliary temperature >37.5
0
C) 
admitted to the medical wards of the three tertiary Hospital were consecutively enrolled into the study until the 
sample size was reached.  
Data collection and laboratory procedures  
After counseling and informed consent, a full history, physical examination and laboratory investigations were 
conducted and recorded in the data collection forms. Data collected included demographic characteristics, 
history of antibiotic/antimalaria use, presenting clinical signs/symptoms, physical 
examination and the current diagnosis. Two blood specimens were collected at the time of study enrolment 
before any antibiotic treatments were initiated at three medical centers to Innovative Biotech, Keffi, Nasarawa 
State. The venipuncture site was disinfected with 70% alcohol and 2% tincture of iodine before collecting 
approximately 10 ml of blood for culture, l-HV serology, and white blood cell counts. For blood culture 5m1 of 
blood was inoculated into 5Oml of Brain Heart Infusion broth (Oxoid UK). Subculture and identification of 
isolates were as described previously [22,23]. Two aerobic blood culture bottles were used for each patient and 
growth in both bottles was considered as significant. All isolates suspected to be Salmonella spp were confirmed 
using polyvalent salmonella Latex identification KIT (Oxoid UK) performed as described by vendor and further 
biochemical tests which included citrate utilization and amount of hydrogen sulphide produced were used to 
differentiate between typhi and non-typhi salmonella [24]. Antibiotic susceptibility was determined by disc 
diffusion on Mueller-Hinton agar and for Streptococcus pneumoniae Mueller-Hinton agar was supplement ed 
with 5% sheep blood. Interpretation was done according to the Clinical Laboratory Standard Institute (CLSI) 
guidelines and Manual for the Laboratory Identification and Antimicrobial Susceptibility Testing of Bacterial 
Pathogens of Public Health Importance in the Developing World [24]. Quality-control of antibiotic discs (Oxoid 
UK), media and incubation conditions was ensured using Escherichia coli ATCC 25922, Streptococcus 
pneumoniae ATCC 49619 and Staphylococcus aureus ATCC 25923 (23,24]. The laboratory is participating in a 
bacteriology external quality assurance coordinated by a reference laboratory in South Africa (WHO/NICD). 
HIV testing was done using a Nigeria National algorithm 1251 and total WBC determined using haematology 
analyzer (Beckman Coulter (UK) Ltd).  
Data analysis  
Data collected were entered into a computer using epidata version 3.1 (CDC, Atlanta, USA) and analyzed using 
STATA version 11 (College Station, Texas, USA). Data were summarized in form of proportions and frequent 
tables for categorical variables. Depending on variable distribution either means with standard deviation or 
medians with interquartile range were used to summarize continuo us data. For non-parametric continuous 
variables Kruskal-Wallis and Mann—Whitney tests were performed to test for the significance of the difference 
of the medians between and within groups respectively. To determine predictors of bacteremia type, the 
multinomial logistic regression analysis was performed, starting with univariate then followed by multivariate 
multinomial logistic regress ion analysis with the nominal outcome being the type of bacteremia namely as no 
bacteremia, bacteremia due to salmonella and bacteremia due to none-salmonella pathogens. Based on patients 
with no bacteremia as the reference group, relative risk ratio with 95% confidence interval was calculated to test 
for strength of association between predictor variables and bacteremia type. On the other hand, to determine the 
predictors of mortality univariate followed by multivariate multinomial logistic regression were performed. Odds 
ratio with 95% confidence interval was calculated to test for strength of association between predictor variables 
and mortality. On both hands analyses, predictors with p-value less than 0.2 on univariate analysis were then 
fitted into the multivariate multinomial logistic regression and predictors with a p-value of less than 0.05 were 
considered to have significant strength of association.  
Ethics statement  
Ethical clearance was obtained from Nasarawa State ministry of Health.  
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Demographic and other characteristics of the study population  
A total of 346 patients were recruited of whom 170 (51.7%) were male and 167 (48.3%) were female The 
median age was 35 years (interquartile range (IQR) 25—48years).The median temperature was 38.5C (IQR 38-
39’C). Of 346 patients 156 (45.1%) were HIV positive; of these, 112 (71.8%) were WHO clinical stage four, 
Only 48/156 (30.8%) of patients with HIV were receiving antiretroviral therapy (ART). See Table 1. A total of 
307 (88.7%) received antibiotic treatment from other hospitals before they were referred to BMC; 33% used 
penicillin group (amoxicillin, ampicillin and cloxacillin), 27% used ceftriaxone, 20% used ciprofloxacin, 18.2% 
used cot rimoxazole, 10.6% used gentamicin, 8.7% used augment in and 7% used chloramphenicol.  
Bacteremia and susceptibility pattern  
Among the 346 febrile adults in our study, 33/346(9.5%) had positive blood stream bacterial infections. Among 
the 33 patients with positive blood cultures, 16/33 (48.5%) were HIV positive. Common bacterial isolates were 
Salmonella spp 13/33 (39.4%), Escherichia coli 8/33 (24.2%), Streptococcus pneumonia 5/33 (15.2%), 
Staphylococcus aureus 4/33 (12.1%), Citrobacter spp 1/33 (3%), Streptococcus pyogenes 1/33 (3%) and 
Kiebsiella pneumonia 1/33 (3%). Of Salmonella spp 12/13 (92.3%) were from HIV patients and all were 
identified as non-typhoid salmonella. Salmonella spp were 84.5%, 69.2%, 38.5%, 23% and 7.6% resistant to 
chloramphenicol, ampicillin, cotrimoxazole, gentamicin and ciprofloxacin respectively. All Salmonella spp 
isolates were sensitive to ceftriaxone and imipenem. Escherichia colt demonstrated multiple resistances to many 
commonly used antibiotics including:  
ampicillin 6/8(75%), cotrimoxazole 6/8(75%), amoxicillin in/clavulanate 5/8 (62.5%), gentamicin 5/8 (62.5%), 
and ciprofloxacin 2/8 (25%).Three isolates (37.5%) were found to be ESBL producers and exhibited resistance 
to ceftazidime, cefotaxime and ceftriaxone.  
Gram positive bacteria were 30% and 40% resistant to ampicillin and cotrimoxazole and they were all sensitive 
to vancomycin and imipenem.  
Table 1 Baseline Demographic and clinical characteristic of 346 febrile adult patients     
           Admitted to 3 medical centers in Nasarawa State, Jan-Mar 2013.     
 CHARACTERISTIC                        PROPORTION (%) OR MEDIAN (IQR) 
 SEX 
 MALE       179(51.7%) 
 FEMALE      167(48.3%) 
 AGE in years                  35(25-48) 
 MARITAL STATUS       
 Never married                  100 (28.9%) 
 Married                   160(46.2%) 
 Divorced      41(11.8%) 
 Widow                    45(13.1%) 
 HIV Status       
 Positive                    156(45.1%) 
 Negative      190 (54.9%) 
 ART Use among 156 HIV-Positive 
 Yes       48 (30.8%) 
 No       108 (69.2%) 
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Table 2 Multivariate logistic regression analysis for predictors mortality for 346 febrile adult patient 
admitted To 3 medical center in Nasarawa State, Jan-Mar 2013. 
PPREDICTIVE FACTOR YES (n=86) (%) MULTIVARIATE OR (95% cl)                                                                                                                                 
                                                                                                                                                    P-Value 
Age (yrs.) 
< 50    21 (31.8)  1 
>50    65(23.2)                  1.7 (0.9-3.2)          0.119 
Fever 
<40 ‘C     7                            6(23.8)                             1 
>40 “C    10 (37.0)  1.5 (0.6-3.7)            0.437 
Vomiting    
No    77 (26.2)   1 
Yes    9 (17.3)    0.7 (0.4-1.7)             0.483 
Neck Stiffness 
No     68 (22.0)   1     
   
Yes    18 (48.7)                           1.6 (0.7-3.7)                         0.266 
HIV 
No    32 (16.8)    1 
Yes     54 (34.6)    2.3 (1.3-3.8)  0.006 
Of HIV infected patients 12 (7.7%) were found to have salmonella bacteremia compared to 1(0.5%) of HIV 
negative patients. By univariate analysis, HIV-infection was found to predict bacteremia in both salmonella and 
non-salmonella bacteremia (RRR 14.8, 95%CI, 19—115, p=0.01). WBC count was found to predict both 
salmonella and non-salmonella bacterial infection, patients with salmonella infection had lower median of WBC 
when compared to patients with non-salmonella infection and those without bacterial infection (median, 3.6 vs. 
17.5 vs. 9.8x109, p=0.0001). The risk of getting non-salmonella bacteremia increases as WBC increases 
(p=O.00l). On univariate as WBC increases by 1*109 there 1.2 times risk of having non-salmonella bacteremia 
compared with patients without bacterial infection; while as WBC increases the risk of salmonella bacteremia 
decreases (RRR= 0.9, p=O.O37). By multivariate analysis HIV positive (RRR 11.2, 95% CI, 1.3-98.7, p=O.029) 
and low ‘WBC were found to predict salmonella bacteremia. 0100 (28.9%) High WBC was found to predict 
non-salmonella bacteremia.  60 (462%) HIV patients with bacteremia had lower CD4+ 41(11.8%) counts than 
HIV patients without bacteremia (27.5 vs. 88 cells/ml, p=O.O1). A total of 54 (34.8%) of HIV infected patients 
die compared to 32 (14.8%) of HIV negative patients (p=O.001, OR 2.6 (1.6-4.3)). On univariate analysis 
these findings were found to be statistically significant. Other factors found to be predict mortality on univariate 
analysis were night sweats (p=O.OO3, OR 2.6 (95%CI 1.4-5.0), neck stiffness (p=O.001, OR 3.4 (1.7-6.8)) and 
anemia (p=O.O01, OR 3.3 (1.7-6.2)). anemia and HIV positive were confirmed to predict mortality on 
multivariate logistic regression analysis (Table 2).  
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Other causes of fever  
Of 346 patients; 97(28%) were found to have positive malaria blood slide; with 9 (2.6%) having both bacteremia 
and malaria. A total of 116 (33.5%) were diagnosed to have tuberculosis using microscopy for AFB and chest X-
ray; of which 79(68.1%) and 37(31.9%) had pulmonary and extra-pulmonary tuberculosis respectively. A total 
of 16(4.6%) of adults were diagnosed to have  bacteremia  
Discussion  
Bacteremia in developed countries accounts for a significant ant burden of disease and has been implicated as the 
11(22.9%) leading cause of non-cardiac death amongst critically ill 5 (10.4%) patients [1,26]. The exact burden 
of bacteremia in low (16.7%) income countries remains unknown. In the present study 1 (2.1%) the prevalence 
of bacteremia among febrile adult patients 1 (21%) was 9.5%; similar findings have been reported in other 242% 
developing countries where routine blood culture is per formed [3, 13]. The finding may be lower than that 1 
(2.1%) reported in developed countries a finding which could be explained by culture techniques used which 
does not favour growth of fastidious organisms. Higher incidences of bacteremia have been reported in 
immunocompromised patients. Several studies [2, 3,] from sub-Saharan Africa have revealed an association 
between HIV infection and an increased likelihood of bacteremia and  
Mortality. This has been confirmed in the present study whereby the bacteremia was significantly higher in HIV 
positive patients than in HIV-negative patients. As in previous studies [3, 15] patients who were HIV positive 
had 11.2 times risk of having non typhoid salmonella bacteremia when compared to HIV-negative patients. 
Studies on bacteremia among febrile adults are few in East Africa. But in a prospective observation study [15] on 
sepsis in two Ugandan Hospitals, it was found that most patients with bacteremia were HIV infected with a 
median CD4+ count of 52 cells/mm3.  Another factor which was found to predict bacteremia in the present study 
is WBC count; both HIV and non-HIV infected patients with non-salmonella bacteremia had higher count of 
total WBC compared to patients with non-typhoid salmonella bacteremia and patients without bacterial 
infection. On the other hand, patients with non-typhoid salmonella bacteremia had a lower WBC count than 
those without bacteremia. Also in this study it was noted HIV patients with bacteremia had significantly lower 
CD4+ count than HIV patients without bacteremia, a finding that is similar to other studies [27,28].Results of 
antimicrobial susceptibility tests revealed that most Salmonella spp were susceptible to ceftriaxone and 
imipenem while being highly resistant to chloramphenicol, ampicillin and cotrimoxazole this has been reported 
before [32]. Resistance rate of 8% of salmonella isolates to ciprofloxacin is relatively high compared to a study 
in Pemba [12] which found resistance rate of 1.2% and in a recent study in Kenya [11] in which none of 
salmonella isolates were found to be resistant to ciprofloxacin m. High resistance rate to ciprofloxacin could be 
explained by the fact that there is overuse of ciprofloxacin m in the primary health facilities; this was confirmed 
in this study. This calls for a continuous surveillance of ciprofloxacin resistance salmonella isolates in our 
setting. Other Gram-negative bacteria also showed good sensitivity patterns to imipenem but they were multiply 
resistant to ampicillin, amoxicillin/clavulanate, gentamicin m and cotrimoxazole. Fifty percent of gram-negative 
enteric isolates were resistant to third-generation cephalosporin. All isolates resistant to third-generation 
cephalosporin were found to produce extended spectrum beta-lactamase. The multi-drug resistance patterns 
observed in this study are similar to those earlier reported [22].  Predictors of mortality were night sweats (p = 
0.014), HIV status (p = 0.006) and Glasgow Coma score (p < 0.001). These findings are similar to a prospective 
observation study on sepsis in two Ugandan hospitals which showed that clinical predictors of in-hospital 
mortality included variables easily measurable in any setting such as morbidity assessment scales (i.e., KPS and 
GCS), vital signs (i.e., RR>30 breaths/mm), leukocytosis and thrombocytopenia[15]. The high mortality among 
HIV infected adults could be explained by the fact majority of them had other co-
morbidities like tuberculosis [5].The present study, thus, established that non-typhoid Salmonella bloodstream 
infection is a common occurrence in HIV-positive patients attending three Medical Centre in Nasarawa state. 
The majority of the study patients with salmonella bloodstream infection had low WBC. The resistance rate to 
commonly used antibiotic is high. Therefore, a continuous surveillance and intervention strategy should be put in 
place to manage cases of bloodstream infections in HIV-positive patients in Nasarawa State, Nigeria. 
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